NewsBenzinga오펜하이머, 파키라 바이오사이언스 투자의견 ‘시장수익률 상회’로 신규 커버리지 개시···목표주가 32달러 제시 오펜하이머, 파키라 바이오사이언스 투자의견 ‘시장수익률 상회’로 신규 커버리지 개시···목표주가 32달러 제시 Benzinga 2026.09.23 10:33 (GMT+0) Open on Benzinga Other news PDS Biotechnology Corporation (PDSB) Discusses PDS-0301 Immunocytokine and Its Role in Treating Metastatic Colorectal Cancer - Slideshow (NASDAQ:PDSB) 2026-10-17 What to Expect From Advanced Micro Devices’ Q3 2026 Earnings Report Here's What to Expect From Uber’s Next Earnings Report Aflac’s Q3 2026 Earnings: What to Expect Marathon Petroleum Earnings Preview: What to Expect American International Group’s Quarterly Earnings Preview: What You Need to Know
PDS Biotechnology Corporation (PDSB) Discusses PDS-0301 Immunocytokine and Its Role in Treating Metastatic Colorectal Cancer - Slideshow (NASDAQ:PDSB) 2026-10-17
